 | • レポートコード：MRC2-11QY11556 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はサイトメガロウイルス（CMV）治療薬のグローバル市場について調査・分析したレポートです。種類別（ガンシクロビル/バルガンシクロビル、ホスカルネット、シドフォビル）市場規模、用途別（CMV網膜炎、肺炎、胃腸潰瘍、脳炎、口内潰瘍、咽頭炎）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別サイトメガロウイルス（CMV）治療薬の競争状況、市場シェア ・世界のサイトメガロウイルス（CMV）治療薬市場：種類別市場規模 2015年-2020年（ガンシクロビル/バルガンシクロビル、ホスカルネット、シドフォビル） ・世界のサイトメガロウイルス（CMV）治療薬市場：種類別市場規模予測 2021年-2026年（ガンシクロビル/バルガンシクロビル、ホスカルネット、シドフォビル） ・世界のサイトメガロウイルス（CMV）治療薬市場：用途別市場規模 2015年-2020年（CMV網膜炎、肺炎、胃腸潰瘍、脳炎、口内潰瘍、咽頭炎） ・世界のサイトメガロウイルス（CMV）治療薬市場：用途別市場規模予測 2021年-2026年（CMV網膜炎、肺炎、胃腸潰瘍、脳炎、口内潰瘍、咽頭炎） ・北米のサイトメガロウイルス（CMV）治療薬市場分析：米国、カナダ ・ヨーロッパのサイトメガロウイルス（CMV）治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのサイトメガロウイルス（CMV）治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のサイトメガロウイルス（CMV）治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのサイトメガロウイルス（CMV）治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie、Actavis、Clinigen Group、Merck、Perrigo Company、Roche、Bausch Health ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Cytomegalovirus Therapeutics Market
The global Cytomegalovirus Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cytomegalovirus Therapeutics Scope and Market Size
Cytomegalovirus Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cytomegalovirus Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AbbVie
Actavis
Clinigen Group
Merck
Perrigo Company
Roche
Bausch Health
…
Market segment by Type, the product can be split into
Ganciclovir/Valganciclovir
Foscarnet
Cidofovir
Market segment by Application, split into
CMV Retinitis
Pneumonia
Gastrointestinal Ulcers
Encephalitis
Mouth Ulcers
Pharyngitis
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cytomegalovirus Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Cytomegalovirus Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Ganciclovir/Valganciclovir
1.4.3 Foscarnet
1.4.4 Cidofovir
1.5 Market by Application
1.5.1 Global Cytomegalovirus Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 CMV Retinitis
1.5.3 Pneumonia
1.5.4 Gastrointestinal Ulcers
1.5.5 Encephalitis
1.5.6 Mouth Ulcers
1.5.7 Pharyngitis
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cytomegalovirus Therapeutics Market Perspective (2015-2026)
2.2 Global Cytomegalovirus Therapeutics Growth Trends by Regions
2.2.1 Cytomegalovirus Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cytomegalovirus Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Cytomegalovirus Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cytomegalovirus Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Cytomegalovirus Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cytomegalovirus Therapeutics Players by Market Size
3.1.1 Global Top Cytomegalovirus Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Cytomegalovirus Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Cytomegalovirus Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cytomegalovirus Therapeutics Market Concentration Ratio
3.2.1 Global Cytomegalovirus Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cytomegalovirus Therapeutics Revenue in 2019
3.3 Cytomegalovirus Therapeutics Key Players Head office and Area Served
3.4 Key Players Cytomegalovirus Therapeutics Product Solution and Service
3.5 Date of Enter into Cytomegalovirus Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cytomegalovirus Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Cytomegalovirus Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cytomegalovirus Therapeutics Market Size by Application (2015-2020)
5.2 Global Cytomegalovirus Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cytomegalovirus Therapeutics Market Size (2015-2020)
6.2 Cytomegalovirus Therapeutics Key Players in North America (2019-2020)
6.3 North America Cytomegalovirus Therapeutics Market Size by Type (2015-2020)
6.4 North America Cytomegalovirus Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cytomegalovirus Therapeutics Market Size (2015-2020)
7.2 Cytomegalovirus Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Cytomegalovirus Therapeutics Market Size by Type (2015-2020)
7.4 Europe Cytomegalovirus Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Cytomegalovirus Therapeutics Market Size (2015-2020)
8.2 Cytomegalovirus Therapeutics Key Players in China (2019-2020)
8.3 China Cytomegalovirus Therapeutics Market Size by Type (2015-2020)
8.4 China Cytomegalovirus Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cytomegalovirus Therapeutics Market Size (2015-2020)
9.2 Cytomegalovirus Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Cytomegalovirus Therapeutics Market Size by Type (2015-2020)
9.4 Japan Cytomegalovirus Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cytomegalovirus Therapeutics Market Size (2015-2020)
10.2 Cytomegalovirus Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cytomegalovirus Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Cytomegalovirus Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Cytomegalovirus Therapeutics Market Size (2015-2020)
11.2 Cytomegalovirus Therapeutics Key Players in India (2019-2020)
11.3 India Cytomegalovirus Therapeutics Market Size by Type (2015-2020)
11.4 India Cytomegalovirus Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cytomegalovirus Therapeutics Market Size (2015-2020)
12.2 Cytomegalovirus Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Cytomegalovirus Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Cytomegalovirus Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview
13.1.3 AbbVie Cytomegalovirus Therapeutics Introduction
13.1.4 AbbVie Revenue in Cytomegalovirus Therapeutics Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Actavis
13.2.1 Actavis Company Details
13.2.2 Actavis Business Overview
13.2.3 Actavis Cytomegalovirus Therapeutics Introduction
13.2.4 Actavis Revenue in Cytomegalovirus Therapeutics Business (2015-2020)
13.2.5 Actavis Recent Development
13.3 Clinigen Group
13.3.1 Clinigen Group Company Details
13.3.2 Clinigen Group Business Overview
13.3.3 Clinigen Group Cytomegalovirus Therapeutics Introduction
13.3.4 Clinigen Group Revenue in Cytomegalovirus Therapeutics Business (2015-2020)
13.3.5 Clinigen Group Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Cytomegalovirus Therapeutics Introduction
13.4.4 Merck Revenue in Cytomegalovirus Therapeutics Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Perrigo Company
13.5.1 Perrigo Company Company Details
13.5.2 Perrigo Company Business Overview
13.5.3 Perrigo Company Cytomegalovirus Therapeutics Introduction
13.5.4 Perrigo Company Revenue in Cytomegalovirus Therapeutics Business (2015-2020)
13.5.5 Perrigo Company Recent Development
13.6 Roche
13.6.1 Roche Company Details
13.6.2 Roche Business Overview
13.6.3 Roche Cytomegalovirus Therapeutics Introduction
13.6.4 Roche Revenue in Cytomegalovirus Therapeutics Business (2015-2020)
13.6.5 Roche Recent Development
13.7 Bausch Health
13.7.1 Bausch Health Company Details
13.7.2 Bausch Health Business Overview
13.7.3 Bausch Health Cytomegalovirus Therapeutics Introduction
13.7.4 Bausch Health Revenue in Cytomegalovirus Therapeutics Business (2015-2020)
13.7.5 Bausch Health Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Cytomegalovirus Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Cytomegalovirus Therapeutics Revenue
Table 3. Ranking of Global Top Cytomegalovirus Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cytomegalovirus Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Ganciclovir/Valganciclovir
Table 6. Key Players of Foscarnet
Table 7. Key Players of Cidofovir
Table 8. Global Cytomegalovirus Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Cytomegalovirus Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Cytomegalovirus Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Cytomegalovirus Therapeutics Market Share by Regions (2015-2020)
Table 12. Global Cytomegalovirus Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Cytomegalovirus Therapeutics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Cytomegalovirus Therapeutics Market Growth Strategy
Table 18. Main Points Interviewed from Key Cytomegalovirus Therapeutics Players
Table 19. Global Cytomegalovirus Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 20. Global Cytomegalovirus Therapeutics Market Share by Players (2015-2020)
Table 21. Global Top Cytomegalovirus Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cytomegalovirus Therapeutics as of 2019)
Table 22. Global Cytomegalovirus Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cytomegalovirus Therapeutics Product Solution and Service
Table 25. Date of Enter into Cytomegalovirus Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cytomegalovirus Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 28. Global Cytomegalovirus Therapeutics Market Size Share by Type (2015-2020)
Table 29. Global Cytomegalovirus Therapeutics Revenue Market Share by Type (2021-2026)
Table 30. Global Cytomegalovirus Therapeutics Market Size Share by Application (2015-2020)
Table 31. Global Cytomegalovirus Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 32. Global Cytomegalovirus Therapeutics Market Size Share by Application (2021-2026)
Table 33. North America Key Players Cytomegalovirus Therapeutics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Cytomegalovirus Therapeutics Market Share (2019-2020)
Table 35. North America Cytomegalovirus Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. North America Cytomegalovirus Therapeutics Market Share by Type (2015-2020)
Table 37. North America Cytomegalovirus Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. North America Cytomegalovirus Therapeutics Market Share by Application (2015-2020)
Table 39. Europe Key Players Cytomegalovirus Therapeutics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Cytomegalovirus Therapeutics Market Share (2019-2020)
Table 41. Europe Cytomegalovirus Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Cytomegalovirus Therapeutics Market Share by Type (2015-2020)
Table 43. Europe Cytomegalovirus Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Cytomegalovirus Therapeutics Market Share by Application (2015-2020)
Table 45. China Key Players Cytomegalovirus Therapeutics Revenue (2019-2020) (Million US$)
Table 46. China Key Players Cytomegalovirus Therapeutics Market Share (2019-2020)
Table 47. China Cytomegalovirus Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. China Cytomegalovirus Therapeutics Market Share by Type (2015-2020)
Table 49. China Cytomegalovirus Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. China Cytomegalovirus Therapeutics Market Share by Application (2015-2020)
Table 51. Japan Key Players Cytomegalovirus Therapeutics Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Cytomegalovirus Therapeutics Market Share (2019-2020)
Table 53. Japan Cytomegalovirus Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Cytomegalovirus Therapeutics Market Share by Type (2015-2020)
Table 55. Japan Cytomegalovirus Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Cytomegalovirus Therapeutics Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Cytomegalovirus Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Cytomegalovirus Therapeutics Market Share (2019-2020)
Table 59. Southeast Asia Cytomegalovirus Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Cytomegalovirus Therapeutics Market Share by Type (2015-2020)
Table 61. Southeast Asia Cytomegalovirus Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Cytomegalovirus Therapeutics Market Share by Application (2015-2020)
Table 63. India Key Players Cytomegalovirus Therapeutics Revenue (2019-2020) (Million US$)
Table 64. India Key Players Cytomegalovirus Therapeutics Market Share (2019-2020)
Table 65. India Cytomegalovirus Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. India Cytomegalovirus Therapeutics Market Share by Type (2015-2020)
Table 67. India Cytomegalovirus Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. India Cytomegalovirus Therapeutics Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Cytomegalovirus Therapeutics Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Cytomegalovirus Therapeutics Market Share (2019-2020)
Table 71. Central & South America Cytomegalovirus Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Cytomegalovirus Therapeutics Market Share by Type (2015-2020)
Table 73. Central & South America Cytomegalovirus Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Cytomegalovirus Therapeutics Market Share by Application (2015-2020)
Table 75. AbbVie Company Details
Table 76. AbbVie Business Overview
Table 77. AbbVie Product
Table 78. AbbVie Revenue in Cytomegalovirus Therapeutics Business (2015-2020) (Million US$)
Table 79. AbbVie Recent Development
Table 80. Actavis Company Details
Table 81. Actavis Business Overview
Table 82. Actavis Product
Table 83. Actavis Revenue in Cytomegalovirus Therapeutics Business (2015-2020) (Million US$)
Table 84. Actavis Recent Development
Table 85. Clinigen Group Company Details
Table 86. Clinigen Group Business Overview
Table 87. Clinigen Group Product
Table 88. Clinigen Group Revenue in Cytomegalovirus Therapeutics Business (2015-2020) (Million US$)
Table 89. Clinigen Group Recent Development
Table 90. Merck Company Details
Table 91. Merck Business Overview
Table 92. Merck Product
Table 93. Merck Revenue in Cytomegalovirus Therapeutics Business (2015-2020) (Million US$)
Table 94. Merck Recent Development
Table 95. Perrigo Company Company Details
Table 96. Perrigo Company Business Overview
Table 97. Perrigo Company Product
Table 98. Perrigo Company Revenue in Cytomegalovirus Therapeutics Business (2015-2020) (Million US$)
Table 99. Perrigo Company Recent Development
Table 100. Roche Company Details
Table 101. Roche Business Overview
Table 102. Roche Product
Table 103. Roche Revenue in Cytomegalovirus Therapeutics Business (2015-2020) (Million US$)
Table 104. Roche Recent Development
Table 105. Bausch Health Company Details
Table 106. Bausch Health Business Overview
Table 107. Bausch Health Product
Table 108. Bausch Health Revenue in Cytomegalovirus Therapeutics Business (2015-2020) (Million US$)
Table 109. Bausch Health Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cytomegalovirus Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Ganciclovir/Valganciclovir Features
Figure 3. Foscarnet Features
Figure 4. Cidofovir Features
Figure 5. Global Cytomegalovirus Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. CMV Retinitis Case Studies
Figure 7. Pneumonia Case Studies
Figure 8. Gastrointestinal Ulcers Case Studies
Figure 9. Encephalitis Case Studies
Figure 10. Mouth Ulcers Case Studies
Figure 11. Pharyngitis Case Studies
Figure 12. Cytomegalovirus Therapeutics Report Years Considered
Figure 13. Global Cytomegalovirus Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Cytomegalovirus Therapeutics Market Share by Regions: 2020 VS 2026
Figure 15. Global Cytomegalovirus Therapeutics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Cytomegalovirus Therapeutics Market Share by Players in 2019
Figure 18. Global Top Cytomegalovirus Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cytomegalovirus Therapeutics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Cytomegalovirus Therapeutics Revenue in 2019
Figure 20. North America Cytomegalovirus Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Cytomegalovirus Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Cytomegalovirus Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Cytomegalovirus Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Cytomegalovirus Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Cytomegalovirus Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Cytomegalovirus Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
サイトメガロウイルス（CMV）網膜炎治療の世界市場（～2026年） Ophthalmology is the branch of medical science that deals with the management and study of anatomy, physiology, and diseases related to the human eye. Globally, the incidence of eye disorders and vision loss are becoming major public health issues. Some of the major eye diseases include age-related …- サイトメガロウイルス（CMV）感染症の世界市場（～2026年） Cytomegalovirus (CMV) infection is one of the common herpesvirus infection with different symptoms, which occurs in people of all ages across the globe. This viral infection is communicable and can easily spread through body fluids such as blood, urine, saliva, semen and breast milk. The infection c…
- サイトメガロウイルス（HHV-5）感染症治療薬の世界市場（～2026年） A drug used to treat giant cell infections. Market Analysis and Insights: Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market The global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of X…
- ヒトサイトメガロウイルス65kDaリンタンパク質の世界市場（～2026年） Market Analysis and Insights: Global Human cytomegalovirus 65 kDa Phosphoprotein Market The global Human cytomegalovirus 65 kDa Phosphoprotein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human cytomegalovirus 65 kD…
- 肺炎治療薬の世界市場（～2026年） Pneumonia is a respiratory disease characterized by inflammation of air sacs in lungs due to bacterial or viral infection. The emergence of advanced diagnostic techniques to be one of the primary factors fueling the growth of the pneumonia therapeutics market in the coming years. Market Analysis and…